Why is Amerise BioScie falling/rising?

As of 24-Oct, Amerise Biosciences Ltd is experiencing a price increase, currently at 0.61, reflecting a change of 0.03 or 5.17% upward. The stock has shown a positive performance today, outperforming its sector by 5.45% and has been on a consecutive gain for the last two days, accumulating a total return of 10.91% during this period. However, it is important to note that the stock's performance over the past month has been negative, with a decline of 7.58%, and a year-to-date drop of 49.59%. The stock is currently trading higher than its 5-day moving average but lower than its longer-term moving averages, indicating mixed momentum. Additionally, there has been a significant decrease in investor participation, with delivery volume falling by 37.82% against the 5-day average, which could suggest waning interest despite the recent price increase.
In the broader market context, Amerise Biosciences Ltd has outperformed the Sensex in the short term, with a 1-week return of 7.02% compared to the Sensex's 0.31%. However, over the longer term, the stock has underperformed significantly, with a year-to-date decline of 49.59% versus the Sensex's gain of 7.77%. This stark contrast highlights the challenges faced by the company despite its recent gains. The lack of available positive or negative factors further complicates the understanding of the stock's recent movements, leaving a gap in the analysis of potential catalysts or headwinds affecting investor sentiment.